The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Johnson & Johnson...as in Boris Johnson!!
Getting desperate EC...
It will be fine another 10% come tommorrow more jam tommorow promises by Newlandas he mugs punters again!
List of biggest pharma Co's in the World.
Interestingly Astrazeneca are ranked 7th in the world and Eisai are 49th (Angle are now working with both).
So our CEO says he is in discussions with another 6 "household names". All of them must be on the list!
See here:-
https://www.visualcapitalist.com/cp/worlds-50-largest-pharmaceutical-companies/
Roche
Johnson & Johnson?
Mms collected shares on the cheap today. The filled their coffers today from impatient peeps.
Miavoce.
"Emerald - AN said that 6 (not 2) of the 11 pharma's they are talking to are household names.".
===================
Just checked and you are correct. 6 other "household names", not 2 as I posted.
My appologies.
GSK?
Emerald - AN said that 6 (not 2) of the 11 pharma's they are talking to are household names.
Would be nice this week. They are taking to another 2 "household names". And another 9 less well known as Mr Newland said in the interview.
Moving away from the 12p 😂😂😂😂🤡
Agreed, my point was that investors remain in the dark about the pace of actual commercial progress (as per usual with Newland). And equally in the dark about revenue build.
I think the FY23 results will be poor, and we could see another retrace back to mid-15s. The spikes in sp on news has just been used by long term holders and day traders to reduce exposure. To punch thro' back to the levels at which last raise was i.e. 80p is going to take some doing....the sp hits resistance every time at 35-30p absent sustained positive commercial newsflow.
Ticked up......
With the recent fantastic news about the contracts with Astrazeneca and Eisai it seems to me any placing could be at a premium the current sp (assuming they don't want to wait up to another year or so to see how the finances are). More common that you might think. I bet you are very very worried?
All IMHO.
With the recent fantastic news about the contracts with Astrazeneca and Eisai it seems to me any placing could be at a premium the sp (assuming they don't want to wait up to another year or so to see how the finances are). More common that you might think. I bet you are very very worried.
All IMHO.
In Angle Plc!!!! LOL!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
No-one is going to believe that. I mean no-one.
I can't believe you posted that.
Another one of your lies no doubt.
I expect an announcement soon on the back of horrid 2023 results.
Great things to come but we need cash funding to keep the lights on..No doubt with the usual charm and persuasion Newland style to mitigate the inevitable share dilution...The target of trebbling revenues to £6.6m this year I believe was a bridge too far!
Analysis via automated AI microscope. The need for clinicians to know the HER2 status of a person with Breast cancer is vital to decide on the most appropriate treatment. In the RNS Angle said this:-
"Given the significant third-party interest in a new assay for quantitative HER2 analysis based on CTCs, ANGLE and Bioview have agreed to allow for the inclusion of third parties in this project and its funding as we move into the commercialisation stage *****after the initial development work is complete*********. The parties are continuing to discuss strategic routes to market with potential corporate partners. ".
The initial development work is complete...............
More potential ££££ and this could be literally any day.
All IMHO.
2good
Why would AZN pay for the development of an assy if the have no intention to use it? You talk garbage. It's not a one off contract
(both top 100 Plc's in their respective Countries) to develop assays (tests) for use during cancer drug trials. Indeed 2 from Astrazeneca (so far). Multi million potential if just one of the 3 cancer trials progress to later stages. Is in discussions with 11 other Companies (at the moment), 2 of them also household names to produce other assays. Once done these assays can also be offered to other Companies.
A market cap of £49m. Some kind of joke, right?
Angle is due a massive re-rating by the market. Massive.
50p a share for starters.
All IMHO.
No BB comments put people off or on to a share. We are all full of hot air and we do not influence the price one iota. We are a speck on a speck on a speck on a full stop. No influence on the market price whatsoever. Delusional to think otherwise.
Emerald if you stop posting for a few days, the price would go up. You are putting people off with your constant ramping. I am long and hold angle
Looks good
Dummy Sell offering me 19.2569, not long now before the blue wave.
EC you're trying way too hard again... 😆 lol!
Making tens of millions from follow on contracts with Eisai and Astrazeneca I think any bid rumours could turn out to be be true. The sp makes Angle dirt cheap. Maybe the next RNS will be about an offer from Illumina?? That would make sense to me. Or Thermo Fisher?
All IMHO.